Valuation : Imexpharm Corporation

Market Cap 5,97600Cr 23Cr 20Cr 19Cr 17Cr 32Cr 2.18TCr 32Cr 220.48Cr 85Cr 1.11TCr 86Cr 84Cr 3.55TCr P/E 2026 *
16.6x
P/E 2027 * 15.3x
Enterprise Value 5,97600Cr 23Cr 20Cr 19Cr 17Cr 32Cr 2.18TCr 32Cr 220.48Cr 85Cr 1.11TCr 86Cr 84Cr 3.55TCr EV / Sales 2026 *
2.25x
EV / Sales 2027 * 2.07x
Free-Float
6.42%
Yield 2026 *
2.62%
Yield 2027 * 2.62%
1 week-4.15%
Current month-4.15%
1 month+3.95%
3 months-16.70%
6 months-29.22%
Current year-27.33%
1 week 36,650
Extreme 36650
39,750
1 month 35,900
Extreme 35900
41,550
Current year 32,650
Extreme 32650
57,000
1 year 32,650
Extreme 32650
57,000
3 years 23,681.82
Extreme 23681.818181
57,000
5 years 18,831.17
Extreme 18831.168829
57,000
10 years 13,036.96
Extreme 13036.963036
57,000
Manager TitleAgeSince
Chief Executive Officer 74 01/08/2001
Director of Finance/CFO 52 18/01/2024
Chief Operating Officer 47 -
Director TitleAgeSince
Chairman 74 01/01/1984
Director/Board Member 50 28/04/2018
Director/Board Member - 30/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
26/09/22 Buy

Chief Executive Officer

1,40,000 0.2100%
20/07/22 Sell

Chief Executive Officer

1,00,000 0.1500%
01/04/22 Exercice

Chairman

50,000 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-4.15%-31.14%+26.44% 23Cr
+0.31%-2.79%+50.24%+89.36% 1,00200Cr
-0.04%-2.20%+52.10%+65.47% 65TCr
+0.36%-4.91%+18.28%+66.99% 44TCr
-0.91%-0.77%+28.48%+36.47% 35TCr
-0.12%-14.86%+9.54%+26.60% 26TCr
-2.11%-3.06%-3.06%+10.55% 25TCr
-0.04%-11.23%+40.41%+50.20% 21TCr
-1.22%-4.28%-14.75%-57.78% 20TCr
-0.73%-2.87%+25.53%+88.63% 18TCr
Average -0.45%-2.27%+17.56%+40.29% 35.44TCr
Weighted average by Cap. -0.24%-2.39%+32.17%+56.11%

Financials

2026 *2027 *
Net sales 2,65900Cr 10Cr 8.8Cr 8.28Cr 7.56Cr 14Cr 970.48Cr 14Cr 98Cr 38Cr 496.04Cr 38Cr 38Cr 1.58TCr 2,88100Cr 11Cr 9.54Cr 8.97Cr 8.19Cr 15Cr 1.05TCr 15Cr 106.3Cr 41Cr 537.45Cr 42Cr 41Cr 1.71TCr
Net income 39TCr 1.52Cr 1.3Cr 1.23Cr 1.12Cr 2.09Cr 143.8Cr 2.1Cr 15Cr 5.62Cr 74Cr 5.7Cr 5.57Cr 233.9Cr 43TCr 1.65Cr 1.42Cr 1.33Cr 1.22Cr 2.27Cr 156.21Cr 2.28Cr 16Cr 6.11Cr 80Cr 6.19Cr 6.05Cr 254.08Cr
Net Debt - -
Logo Imexpharm Corporation
Imexpharm Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. It is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.
Employees
1,438
Date Price Change Volume
09/26/09 ₫38,800.00 +1.70% 4,346
08/26/08 ₫38,150.00 0.00% 1,446
07/26/07 ₫38,150.00 -1.93% 9,251
04/26/04 ₫38,900.00 -1.27% 4,558
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
38,150.00VND
Average target price
56,000.00VND
Spread / Average Target
+46.79%

Annual profits - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!